Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) on Monday, plunged -6.05% from the previous trading day, before settling in for the closing price of $26.61. Within the past 52 weeks, AMPH’s price has moved between $25.89 and $53.96.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 18.07% over the past five years. The company achieved an average annual earnings per share of -19.21%. With a float of $35.19 million, this company’s outstanding shares have now reached $47.62 million.
Let’s look at the performance matrix of the company that is accounted for 2028 employees. In terms of profitability, gross margin is 50.4%, operating margin of 28.14%, and the pretax margin is 25.99%.
Amphastar Pharmaceuticals Inc (AMPH) Insider and Institutional Ownership
Observing investor behavior towards Drug Manufacturers – Specialty & Generic industry stocks is more important than anything else. The insider ownership of Amphastar Pharmaceuticals Inc is 26.15%, while institutional ownership is 74.96%. The most recent insider transaction that took place on Apr 01 ’25, was worth 14,190. In this transaction Director of this company sold 500 shares at a rate of $28.38, taking the stock ownership to the 73,909 shares. Before that another transaction happened on Apr 01 ’25, when Company’s Director proposed sale 500 for $28.86, making the entire transaction worth $14,430.
Amphastar Pharmaceuticals Inc (AMPH) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -19.21% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -0.04% during the next five years compared to 25.59% growth over the previous five years of trading.
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Trading Performance Indicators
Amphastar Pharmaceuticals Inc (AMPH) is currently performing well based on its current performance indicators. A quick ratio of 2.19 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.63. Likewise, its price to free cash flow for the trailing twelve months is 6.91.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 3.06, a number that is poised to hit 0.69 in the next quarter and is forecasted to reach 3.68 in one year’s time.
Technical Analysis of Amphastar Pharmaceuticals Inc (AMPH)
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) saw its 5-day average volume 0.82 million, a positive change from its year-to-date volume of 0.61 million. As of the previous 9 days, the stock’s Stochastic %D was 12.15%. Additionally, its Average True Range was 1.07.
During the past 100 days, Amphastar Pharmaceuticals Inc’s (AMPH) raw stochastic average was set at 1.19%, which indicates a significant decrease from 6.36% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 33.00% in the past 14 days, which was lower than the 34.85% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $30.12, while its 200-day Moving Average is $40.34. Nevertheless, the first resistance level for the watch stands at $25.73 in the near term. At $26.45, the stock is likely to face the second major resistance level. The third major resistance level sits at $26.96. If the price goes on to break the first support level at $24.49, it is likely to go to the next support level at $23.98. The third support level lies at $23.26 if the price breaches the second support level.
Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) Key Stats
Market capitalization of the company is 1.19 billion based on 47,650K outstanding shares. Right now, sales total 731,970 K and income totals 159,520 K. The company made 186,520 K in profit during its latest quarter, and 37,960 K in sales during its previous quarter.
